Regarding the clinical significance of naïve CD8+ T cells, it has been suggested that levels of naïve CD8+ T cells may be a prognostic indicator for oligometastatic non-small cell lung cancer patients and are reduced in patients with chronic kidney disease (CKD) [41,42]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.